AB

Ankitkumar Bharatparvat Goswami

Active Director Director DIN 10453305
DIN 10453305 First appointment Sep 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Ankitkumar Bharatparvat Goswami

Data last updated:

Ankitkumar Bharatparvat Goswami is a Director at Paamcare Pharmaceuticals Private Limited (since 2024). The company operates in Pharma.

DIN 10453305
Primary Designation Director
Industry Pharma
First Appointment 30 Sep 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Sep 20242024Active

Board colleagues of Ankitkumar Bharatparvat Goswami

Directorship timeline

Open interactive timeline →
Paamcare Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ankitkumar Bharatparvat Goswami

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ankitkumar Bharatparvat Goswami

Ankitkumar Bharatparvat Goswami currently holds 1 directorship: Paamcare Pharmaceuticals Private Limited (Director, since 30 Sep 2024).

Ankitkumar Bharatparvat Goswami was first appointed on 30 Sep 2024 as Director at Paamcare Pharmaceuticals Private Limited.

The current boards of Ankitkumar Bharatparvat Goswami's companies include Maulikkumar Vinodbhai Vasoya (Paamcare Pharmaceuticals Private Limited), Pankaj Maganbhai Parmar (Paamcare Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available